- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.13 | - |
NAV | ₹15.42 | - |
Fund Started | 14 Sep 2023 | - |
Fund Size | ₹1568.02 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 30 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.13
-
NAV
₹15.42
-
Fund Started
14 Sep 2023
-
Fund Size
₹1568.02 Cr
-
Exit Load
Exit load of 1%, if redeemed within 30 days.
-
Returns
1 Year | 22.25% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
22.25%
-
3 Year
-
-
5 Year
-
-
Holding Analysis
Equity | 99.10% | - |
Cash | 0.90% | - |
Equity
99.10%
-
Cash
0.90%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.29% |
Divi's Laboratories Ltd. | 8.50% |
Cipla Ltd. | 7.68% |
Lupin Ltd. | 5.35% |
Max Healthcare Institute Ltd. | 4.95% |
Krishna Institute of Medical Sciences Ltd | 4.01% |
Torrent Pharmaceuticals Ltd. | 3.83% |
Aster DM Healthcare Ltd. | 3.75% |
Ipca Laboratories Ltd. | 3.26% |
Glenmark Pharmaceuticals Ltd. | 3.18% |
-
Fund Manager
Name | Dhruv Muchhal | - |
Start Date | 14 Sep 2023 | - |
Name
Dhruv Muchhal
-
Start Date
14 Sep 2023
-
About Fund
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | - |
Launch Date | 14 Sep 2023 | - |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
-
Launch Date
14 Sep 2023
-
